Dehradun, Jan. 22 -- Garhwal Post Bureau
Roorkee, 20 Jan: In a significant step towards affordable healthcare, pandemic preparedness, and indigenous biotechnology innovation, the Indian Institute of Technology Roorkee (IIT Roorkee) has developed a next-generation antibody discovery platform with the potential to transform diagnostics and therapeutics for diseases of national and global importance.
The breakthrough research, led by scientists at IIT Roorkee, involves the development of an ultra-large, high-diversity single-domain antibody (nanobody) library. The platform enables rapid identification of highly stable and high-affinity antibodies against a wide range of targets, including infectious diseases, cancer, autoimmune disorders, an...